| Year |
Citation |
Score |
| 2019 |
Laack NN, Pugh SL, Brown PD, Fox S, Wefel JS, Meyers C, Choucair A, Khuntia D, Suh JH, Roberge D, Wendland MM, Bruner D. The association of health-related quality of life and cognitive function in patients receiving memantine for the prevention of cognitive dysfunction during whole-brain radiotherapy. Neuro-Oncology Practice. 6: 274-282. PMID 31386073 DOI: 10.1093/Nop/Npy038 |
0.449 |
|
| 2019 |
Wefel J, Pugh S, Choucair A, Fisher B, Fox S, Meyers C, Ashby L, Mikkelsen T, Glass J, Yu M, Howard S, Movsas B, Mehta M. NCOG-01. NEUROCOGNITIVE FUNCTION (NCF) AND QUALITY OF LIFE (QOL) RESULTS FROM A PHASE II STUDY OF TEMOZOLOMIDE-BASED CHEMORADIOTHERAPY REGIMEN FOR HIGH RISK LOW-GRADE GLIOMAS Neuro-Oncology. 21: vi158-vi159. DOI: 10.1093/Neuonc/Noz175.663 |
0.416 |
|
| 2014 |
Gerstenecker A, Nabors LB, Meneses K, Fiveash JB, Marson DC, Cutter G, Martin RC, Meyers CA, Triebel KL. Cognition in patients with newly diagnosed brain metastasis: profiles and implications. Journal of Neuro-Oncology. 120: 179-85. PMID 25035099 DOI: 10.1007/S11060-014-1543-X |
0.364 |
|
| 2014 |
Escalante CP, Meyers C, Reuben JM, Wang X, Qiao W, Manzullo E, Alvarez RH, Morrow PK, Gonzalez-Angulo AM, Wang XS, Mendoza T, Liu W, Holmes H, Hwang J, Pisters K, et al. A randomized, double-blind, 2-period, placebo-controlled crossover trial of a sustained-release methylphenidate in the treatment of fatigue in cancer patients. Cancer Journal (Sudbury, Mass.). 20: 8-14. PMID 24445757 DOI: 10.1097/Ppo.0000000000000018 |
0.382 |
|
| 2014 |
Wefel JS, Vidrine DJ, Marani SK, Swartz RJ, Veramonti TL, Meyers CA, Hoekstra HJ, Hoekstra-Weebers JEHM, Gritz ER. A prospective study of cognitive function in men with non-seminomatous germ cell tumors Psycho-Oncology. 23: 626-633. PMID 24339329 DOI: 10.1002/Pon.3453 |
0.304 |
|
| 2013 |
Brown PD, Pugh S, Laack NN, Wefel JS, Khuntia D, Meyers C, Choucair A, Fox S, Suh JH, Roberge D, Kavadi V, Bentzen SM, Mehta MP, Watkins-Bruner D. Memantine for the prevention of cognitive dysfunction in patients receiving whole-brain radiotherapy: a randomized, double-blind, placebo-controlled trial. Neuro-Oncology. 15: 1429-37. PMID 23956241 DOI: 10.1093/Neuonc/Not114 |
0.438 |
|
| 2013 |
Milbury K, Chaoul A, Biegler K, Wangyal T, Spelman A, Meyers CA, Arun B, Palmer JL, Taylor J, Cohen L. Tibetan sound meditation for cognitive dysfunction: results of a randomized controlled pilot trial. Psycho-Oncology. 22: 2354-63. PMID 23657969 DOI: 10.1002/Pon.3296 |
0.31 |
|
| 2012 |
Johnson DR, Sawyer AM, Meyers CA, O'Neill BP, Wefel JS. Early measures of cognitive function predict survival in patients with newly diagnosed glioblastoma. Neuro-Oncology. 14: 808-16. PMID 22508762 DOI: 10.1093/neuonc/nos082 |
0.343 |
|
| 2011 |
Wu AS, Witgert ME, Lang FF, Xiao L, Bekele BN, Meyers CA, Ferson D, Wefel JS. Neurocognitive function before and after surgery for insular gliomas. Journal of Neurosurgery. 115: 1115-25. PMID 21905800 DOI: 10.3171/2011.8.Jns11488 |
0.396 |
|
| 2011 |
Witgert ME, Meyers CA. Neurocognitive and quality of life measures in patients with metastatic brain disease. Neurosurgery Clinics of North America. 22: 79-85, vii. PMID 21109152 DOI: 10.1016/j.nec.2010.08.010 |
0.399 |
|
| 2011 |
Wolfson AH, Bae K, Komaki R, Meyers C, Movsas B, Le Pechoux C, Werner-Wasik M, Videtic GM, Garces YI, Choy H. Primary analysis of a phase II randomized trial Radiation Therapy Oncology Group (RTOG) 0212: impact of different total doses and schedules of prophylactic cranial irradiation on chronic neurotoxicity and quality of life for patients with limited-disease small-cell lung cancer. International Journal of Radiation Oncology, Biology, Physics. 81: 77-84. PMID 20800380 DOI: 10.1016/J.Ijrobp.2010.05.013 |
0.359 |
|
| 2011 |
Wefel JS, Vidrine DJ, Veramonti TL, Meyers CA, Marani SK, Hoekstra HJ, Hoekstra-Weebers JEHM, Shahani L, Gritz ER. Cognitive impairment in men with testicular cancer prior to adjuvant therapy Cancer. 117: 190-196. PMID 20737560 DOI: 10.1002/cncr.25298 |
0.319 |
|
| 2010 |
Wefel JS, Saleeba AK, Buzdar AU, Meyers CA. Acute and late onset cognitive dysfunction associated with chemotherapy in women with breast cancer. Cancer. 116: 3348-56. PMID 20564075 DOI: 10.1002/cncr.25098 |
0.319 |
|
| 2009 |
Benge JF, Perrier ND, Massman PJ, Meyers CA, Kayl AE, Wefel JS. Cognitive and affective sequelae of primary hyperparathyroidism and early response to parathyroidectomy. Journal of the International Neuropsychological Society : Jins. 15: 1002-11. PMID 19807940 DOI: 10.1017/S1355617709990695 |
0.35 |
|
| 2009 |
Friedman MA, Fernandez M, Wefel JS, Myszka KA, Champlin RE, Meyers CA. Course of cognitive decline in hematopoietic stem cell transplantation: a within-subjects design. Archives of Clinical Neuropsychology : the Official Journal of the National Academy of Neuropsychologists. 24: 689-98. PMID 19767298 DOI: 10.1093/Arclin/Acp060 |
0.621 |
|
| 2009 |
Groves MD, Puduvalli VK, Gilbert MR, Levin VA, Conrad CA, Liu VH, Hunter K, Meyers C, Hess KR, Alfred Yung WK. Two phase II trials of temozolomide with interferon-α2b (pegylated and non-pegylated) in patients with recurrent glioblastoma multiforme British Journal of Cancer. 101: 615-620. PMID 19672263 DOI: 10.1038/Sj.Bjc.6605189 |
0.358 |
|
| 2009 |
Dickinson MD, Barr CD, Hiscock M, Meyers CA. Cognitive effects of pegylated interferon in individuals with primary brain tumors. Journal of Neuro-Oncology. 95: 231-7. PMID 19484406 DOI: 10.1007/S11060-009-9920-6 |
0.4 |
|
| 2009 |
Wolfson A, Bae K, Komaki R, Meyers C, Movsas B, Pechoux CL, Werner-Wasik M, Videtic G, Garces Y, Choy H. Secondary Endpoints of a Phase II Randomized Trial (RTOG 0212): Impact of Different Total Doses and Schedules of Prophylactic Cranial Irradiation on Chronic Neurotoxicity and Quality of Life for Patients with Limited Disease Small-cell Lung Cancer International Journal of Radiation Oncology Biology Physics. 75. DOI: 10.1016/J.Ijrobp.2009.07.099 |
0.3 |
|
| 2009 |
Movsas B, Bae K, Meyers C, Gore E, Bonner J, Sun A, Schild S, Gaspar LE, Bogart J, Choy H. Phase III Study of Prophylactic Cranial Irradiation vs. Observation in Patients with Stage III Non–small-cell Lung Cancer: Neurocognitive and Quality of Life Analysis of RTOG 0214 International Journal of Radiation Oncology Biology Physics. 75. DOI: 10.1016/J.Ijrobp.2009.07.030 |
0.347 |
|
| 2008 |
Dietrich J, Monje M, Wefel J, Meyers C. Clinical patterns and biological correlates of cognitive dysfunction associated with cancer therapy Oncologist. 13: 1285-1295. PMID 19019972 DOI: 10.1634/Theoncologist.2008-0130 |
0.337 |
|
| 2008 |
Friedman MA, Meyers CA, Sawaya R. Neuropsychological effects of third ventricle tumor surgery. Neurosurgery. 62: 1093-100. PMID 18695530 DOI: 10.1227/01.neu.0000333775.81563.91 |
0.666 |
|
| 2008 |
Wefel JS, Witgert ME, Meyers CA. Neuropsychological sequelae of non-central nervous system cancer and cancer therapy. Neuropsychology Review. 18: 121-31. PMID 18415683 DOI: 10.1007/s11065-008-9058-x |
0.325 |
|
| 2006 |
Rivera E, Meyers C, Groves M, Valero V, Francis D, Arun B, Broglio K, Yin G, Hortobagyi GN, Buchholz T. Phase I study of capecitabine in combination with temozolomide in the treatment of patients with brain metastases from breast carcinoma. Cancer. 107: 1348-54. PMID 16909414 DOI: 10.1002/Cncr.22127 |
0.383 |
|
| 2006 |
Kayl AE, Wefel JS, Meyers CA. Chemotherapy and cognition: effects, potential mechanisms, and management. American Journal of Therapeutics. 13: 362-9. PMID 16858172 DOI: 10.1097/00045391-200607000-00013 |
0.378 |
|
| 2006 |
Meyers CA, Brown PD. Role and relevance of neurocognitive assessment in clinical trials of patients with CNS tumors. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 24: 1305-9. PMID 16525186 DOI: 10.1200/JCO.2005.04.6086 |
0.369 |
|
| 2006 |
Vadhan-Raj S, Trent J, Patel S, Collard M, Bueso-Ramos CE, Cleeland C, Benjamin R, Meyers C. Effects of Darbepoetin Alfa Administered Once Per Cycle for the Prevention of Anemia on the Incidence of Transfusions, Neurocognitive Functions, and Symptom Assessment. Blood. 108: 4232-4232. DOI: 10.1182/Blood.V108.11.4232.4232 |
0.343 |
|
| 2003 |
Kayl AE, Meyers CA. Does brain tumor histology influence cognitive function? Neuro-Oncology. 5: 255-60. PMID 14565162 DOI: 10.1215/S1152851703000012 |
0.36 |
|
| 2003 |
Herman MA, Tremont-Lukats I, Meyers CA, Trask DD, Froseth C, Renschler MF, Mehta MP. Neurocognitive and functional assessment of patients with brain metastases: a pilot study. American Journal of Clinical Oncology. 26: 273-9. PMID 12796600 DOI: 10.1097/01.COC.0000020585.85901.7C |
0.356 |
|
| 2003 |
Meyers CA, Hess KR. Multifaceted end points in brain tumor clinical trials: cognitive deterioration precedes MRI progression. Neuro-Oncology. 5: 89-95. PMID 12672280 DOI: 10.1093/NEUONC/5.2.89 |
0.423 |
|
| 2003 |
Friedman MA, Meyers CA, Sawaya R. Neuropsychological effects of third ventricle tumor surgery. Neurosurgery. 52: 791-8; discussion 79. PMID 12657174 |
0.666 |
|
| 2002 |
Sherman AM, Jaeckle K, Meyers CA. Pretreatment cognitive performance predicts survival in patients with leptomeningeal disease. Cancer. 95: 1311-6. PMID 12216100 DOI: 10.1002/cncr.10816 |
0.316 |
|
| 2002 |
Mehta M, Rodrigus P, Terhaard C, Rao A, Suh J, Roa W, Shapiro W, Glantz M, Patchell R, Weitzner M, Souhami L, Bezjak A, Leibenhaut M, Komaki R, Schultz C, ... ... Meyers C, et al. Motexafin gadolinium prolongs time to neurologic progression in lung cancer patients with brain metastases: results of a randomized phase III trial International Journal of Radiation Oncology Biology Physics. 54: 92. DOI: 10.1016/S0360-3016(02)03215-7 |
0.333 |
|
| 1999 |
Groves MD, Maor MH, Meyers C, Kyritsis AP, Jaeckle KA, Yung WK, Sawaya RE, Hess K, Bruner JM, Peterson P, Levin VA. A phase II trial of high-dose bromodeoxyuridine with accelerated fractionation radiotherapy followed by procarbazine, lomustine, and vincristine for glioblastoma multiforme. International Journal of Radiation Oncology, Biology, Physics. 45: 127-35. PMID 10477016 DOI: 10.1016/S0360-3016(99)00122-4 |
0.334 |
|
| 1998 |
Meyers CA. Neurobehavioral functioning of adults with pituitary disease Psychotherapy and Psychosomatics. 67: 168-172. PMID 9667064 DOI: 10.1159/000012277 |
0.345 |
|
| 1998 |
Sherer M, Meyers C, Bergloff P. Neuropsychological rehabilitation of patients with primary malignant brain tumors Archives of Clinical Neuropsychology. 13: 74-74. DOI: 10.1016/S0887-6177(98)90495-4 |
0.434 |
|
| 1997 |
Pazdur R, Meyers C, Diaz-Canton E, Abbruzzese JL, Patt Y, Grove W, Ajani JA. Phase II trial of intravenous CI-980 (NSC 370147) in patients with metastatic colorectal carcinoma. Model for prospective evaluation of neurotoxicity. American Journal of Clinical Oncology. 20: 573-576. PMID 9391543 DOI: 10.1097/00000421-199712000-00008 |
0.352 |
|
| Show low-probability matches. |